4-Fluoro-2-trifluoromethylbenzonitrile

We are 4-Fluoro-2-trifluoromethylbenzonitrile CAS:194853-86-6 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:4-Fluoro-2-trifluoromethylbenzonitrile
CAS.NO:194853-86-6
Synonyms:4-Fluoro-2-trifluoromethylbenzonitrile
4-fluoro-2-(trifluoromethyl)benzenecarbonitrile
4-cyano-(3-trifluoromethyl)fluorobenzene
 
Physical and Chemical Properties:
Density 1.4±0.1 g/cm3
Boiling Point 204.1±35.0 °C at 760 mmHg
Melting Point 43-45°C
Molecular Formula C8H3F4N
Molecular Weight 189.110
Flash Point 98.4±17.3 °C
Vapour Pressure 0.3±0.4 mmHg at 25°C
Index of Refraction 1.444
 
Specification:
Appearance:White to yellow crystals
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Organic synthesis.

4-Fluoro-2-trifluoromethylbenzonitrile


Related News: Saudi Arabia’s state airline and Oman also suspended flights to China on Sunday in reaction to the coronavirus epidemic, according to Reuters.N-[(2R,3S)-2-(2,5-Difluorophenyl)tetrahydro-5-oxo-2H-pyran-3-yl]carbamic acid 1,1-dimethylethyl ester CAS:951127-25-6 Saudi Arabia’s state airline and Oman also suspended flights to China on Sunday in reaction to the coronavirus epidemic, according to Reuters.arsorosomethane CAS:593-58-8 CMO services mainly involve four stages: pre-clinical research, clinical trials, sales of patented drugs after listing, and sales of original drug products after patents expire. Its advantages are: lower cost, guaranteed quality, good capacity flexibility, and favorable process Promotion.3-fluoroanilina CAS:372-19-0 CMO services mainly involve four stages: pre-clinical research, clinical trials, sales of patented drugs after listing, and sales of original drug products after patents expire. Its advantages are: lower cost, guaranteed quality, good capacity flexibility, and favorable process Promotion.Steven M. Fruchtman, M.D., President and Chief Executive Officer of Onconova, added “The rigosertib Pre-approval Access Program is a key strategic initiative for Onconova.

Related Products
Product Name
3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylic acid View Details
6-Methoxyguanine View Details
3-Nitrobenzotrifluoride View Details
2,3,4-Trifluorobenzonitrile manufacturer Melanotan-1 manufacturer 1,2-Octanediol manufacturer DL-Phenylalanine manufacturer Adenosine-5′-diphosphate disodium salt manufacturer